【LKL 0182 交流专区】

Tony-Pua

进军东盟非洲市场 LKL国际放眼扩大海外业务
财经新闻 财经  2016-05-17 10:59
http://www.nanyang.com/node/761685?tid=462

（吉隆坡16日讯）除了巩固国内的业务，LKL国际（LKL，0182，创业板）放眼在未来扩大海外业务版图，尤其是东盟和非洲市场。总经理林柏鸿在上市鸣锣仪式后的记者会上指出，目前，公司在国内市占率达40.5%，同时出口产品至全球6大洲和超过30个国外市场。

他对于公司在市场上强稳的立足点和高素质产品，有信心能攫取更大的市占率。

“扩大海外业务是公司的发展计划之一，因此，将积极探讨进军更多的新市场。”

他说，公司目前专注于渗透东盟市场，除了东盟10大国家，同时也会探讨扩大非洲市场，因此将会在这两个区域付出更多的努力和措施。

根据2015财年的营业额，该公司的国内销售占80.51%，海外出口则贡献19.49%。

尽管经济格局不明朗，不过林柏鸿仍看好医疗保健服务领域的增长展望，尤其政府在第11大马计划下，放眼提升高素质医疗服务。

“（政府放眼）将每1000人对1.9张床位，提升至2.3张，因此，有利于推动公司的业务和盈利增长。”

提及国内的医疗保健集团积极增设医院之际会否推动订单？他则说，目前这些集团还未公开招标，不过，公司将会积极的接洽。

新机械提高年产能30%

LKL国际通过上市筹获2260万令吉，其中部分资金将用以购买3台电脑数值控制机械（CNC），减少对劳力的依赖，加强营运效率和产能。

一旦引起新仪器，该公司估计将每年的产能额外提升30%。

拨399万还贷

同时，公司也拨出399万5000令吉偿还银行贷款，将截至去年10月31日的0.28倍负债率，减低至0.1倍。

LKL国际和独资子公司LKL先进医疗器材私人有限公司（LKL Advance Metaltech），主要业务是从事设计和制造医疗用途病床、周边医疗用品和配件，并销售予国内外私人和政府医院及医疗中心。

值得一提的是，LKL先进医疗器材私人有限公司曾是《南洋商报》2015年卓越金鹰奖的得主之一。

股价首日飙40%

今日在马交所上市的LKL国际，以亮眼的表现登场，股价首日走势强稳。

该公司上市发售价为20仙，今日首宗交易以35仙开跑，溢价15仙或75%，成交量达990万股。

不过，该股稍后回吐部分的涨幅，闭市时，LKL国际收报28仙，全日涨8仙或40%，成交量达1亿3296万200股。

同时，LKL国际分别晋升热门榜及上升榜的第1和第12位置。

针对股价走势的看法，林柏鸿指出，公司今日的股价录得亮眼的溢价，表现强稳。

鸣锣上市仪式的出席者，包括LKL国际董事经理林观年、非独立非执行董事陈全福、执行董事莫美兰、独立非执行主席丹斯里阿兹米、高级独立非执行董事特维乃甘、独立非执行董事瑟玛依诺丽、财务总监王勤礼。

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Apr 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Apr 2016	30 Apr 2015	30 Apr 2016	30 Apr 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	9,311		37,149	39,039
2	Profit/(loss) before tax	-498		5,135	7,298
3	Profit/(loss) for the period	-612		3,517	5,962
4	Profit/(loss) attributable to ordinary equity holders of the parent	-612		3,517	5,962
5	Basic earnings/(loss) per share (Subunit)	-0.19		1.11	1.89
6	Proposed/Declared dividend per share (Subunit)	0.00		0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1100		20.8700

icy97

LKL国际购钢板冲孔机 以满足更高需求
By Kamarul Anwar / theedgemarkets.com   | August 8, 2016 : 7:48 PM MYT

（吉隆坡8日讯）新上市的LKL国际（LKL International Bhd）已购入一台全自动电脑数控（CNC）冲孔机，使该集团可提高生产效率和赶上医疗保健设施不断上升的需求。

这家医疗保健床和辅助设备制造商今日向大马交易所报备，已与德国的TRUMPF Group签署采购合约，以31万8000欧元（约144万令吉）收购冲孔机。

LKL国际表示，该机器预计在付款后的5至6个月内交付和安装。

数控冲孔机将主要用于生产线中的钢板冲压程序。

LKL国际董事经理林观年说：“医疗保健领域的市场需求似乎保持弹性，这使我们能够更积极拓展业务。我们相信，有了新添购的数控冲孔机，将能够满足日后大批的需求。”

（编译：陈慧珊）

Type	Announcement
Subject	OTHERS
Description	LKL INTERNATIONAL BERHAD ("LKL INTERNATIONAL" OR "COMPANY")- LKL INTERNATIONAL BERHAD TO ACQUIRE CNC PUNCHING MACHINE AS PART OF BUSINESS EXPANSION PLAN
We are pleased to attach a press release dated 8 August 2016 entitled "LKL International Berhad to acquire CNC Punching Machine as part of business expansion plan".

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5170589

Attachments Press Release - LKL Signs sales contract with TRUMPF Gruppe.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Jul 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Jul 2016	31 Jul 2015	31 Jul 2016	31 Jul 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	11,924		11,924
2	Profit/(loss) before tax	2,214		2,214
3	Profit/(loss) for the period	1,627		1,627
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,627		1,627
5	Basic earnings/(loss) per share (Subunit)	0.39		0.39
6	Proposed/Declared dividend per share (Subunit)	0.00		0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1400		0.1100

icy97

放眼产品获FDA认证
LKL国际明年进军美国

2016年9月28日
（吉隆坡27日讯）LKL国际（LKL，0182，创业板）放眼旗下产品，能够获得美国食品药品监管局（FDA）认证，并从明年开始进军美国市场。

LKL国际董事经理林观年，今天在股东大会后向媒体表示：“公司目前正申请FDA的认证，预计3至6个月会有结果。”

美国FDA隶属于美国国务院保健与服务部的公共健康服务署，负责监管美国所有食品、药品、化妆品及辐射性仪器。

刚刚在今年5月16日上市的LKL国际，主要业务是向医院和医疗中心，提供医疗或保健用途病床，以及周边产品等配件。

国际很多厂商都以追求获得FDA 认证，作为产品品质的最高荣誉和保证。

现阶段，LKL国际80%的营业额来自本地市场，剩余20%则来自海外市场。

林观年说，若成功进军美国，相信海外市场对公司的营业额贡献会增加。

计划扩展南亚

此外，公司也打算扩展南亚市场，并预计印度降低进口税对公司有利。

出席股东大会的高层，还包括执行董事莫美兰、独立非执行主席丹斯里阿兹米、非独立非执行董事陈全福，以及高级独立非执行董事迪瓦奈甘。

450万购德国镭射切割机

另一方面， LKL国际计划在明年以450万令吉，从德国购置一架镭射切割机。

林观年说，之前订购的全自动电脑数值控制工具（CNC）打孔机，会在今年11月运抵。

“这些机器运抵后，相信会提高公司生产力30%，并减少外劳的工作量。”

他说，公司不会裁减生产部的外劳，而会安排到其他部门工作，如组装部。

目前，LKL国际每年平均生产4000至5000张病床。

“其实，我们还有很多其他的医疗器材，拥有超过1万个量身定做的医疗器材种类。”

他说，每家医院都有本身的标准，而公司会依据客户的需求，量身定做医疗器材。

“当然，这些量身定做医疗器材的价钱，会比普通产品高一些，因为牵涉到研发和绘图等。”

林观年也披露，公司最近刚接获来自巴基斯坦约500至600张病床的订单。

首季赚163万

尽管市场充满挑战，但他相信医疗业务仍持续增长。

截至7月31日，LKL国际（LKL，0182，创业板）首季净赚162万7000令吉，相等于每股0.39仙，同期营业额则达1192万4000令吉。

业绩是由医疗保健用的床褥及周边产品销量推动，各别达到328万令吉和596万9000令吉。

由于该公司首次上市创业板，没有中期财务报告，因此无法进行比较。

展望未来，LKL国际将着重于拓展本地以及海外地位和市占率。【e南洋】

icy97

Type	Announcement
Subject	OTHERS
Description	LKL INTERNATIONAL BERHAD ("LKL INTERNATIONAL" OR "THE COMPANY")ACQUISITION OF NEW WHOLLY-OWNED SUBSIDIARY NAMELY MEDIK GEN SDN. BHD. ("MEDIK GEN")
The Board of Directors of LKL International wishes to announce that the Company has on 10 October 2016 acquired the entire issued and paid up share capital of Medik Gen for a total cash consideration of RM100.00 (“the Acquisition”). Upon the Acquisition, Medik Gen will become a wholly-owned subsidiary of the Company. Medik Gen was incorporated in Malaysia on 27 October 2014 under the Companies Act, 1965 as a private limited company. Presently, the authorised share capital of Medik Gen is RM400,000.00 divided into 400,000 ordinary shares of RM1.00 each and the issued and paid-up share capital is RM100.00 comprising 100 ordinary shares of RM1.00 each. The Company has not commenced its business operation since its incorporation and the intended principal activities of Medik Gen is trading of hospital furniture, laboratory furniture, medical equipment, utensils and accessories. The Acquisition has no material effect on the earnings per share, net tangible assets per share, share capital and the substantial shareholdings of the Company for the financial year ending 30 April 2017. None of the directors and/or major shareholders of LKL International and/or persons connected with them, has any interest, direct or indirect, in the Acquisition. This announcement is dated 10 October 2016.

icy97

LKL國際斥524萬購地

2016年10月20日
（吉隆坡20日訊）LKL國際（LKL，0182，創業板消費）擬斥資524萬7000令吉購地。

LKL國際向馬證交所報備，子公司LKL Advance Metaltech私人有限公司與Jengkal Semaju私人有限公司簽署買賣協議，以524萬7000令吉向后者收購位于史里肯邦安的地皮，包括半層廠房。

根據報備文件，是項收購料不會為LKL國際截至4月底2017財年末的收益、每股盈利、淨資產和負債率造成實質的影響。【中国报财经】

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	LKL INTERNATIONAL BERHAD ("LKL INTERNATIONAL" OR "THE COMPANY")PROPOSED ACQUISITION OF ALL THAT PIECE OF FREEHOLD LAND TOGETHER WITH A ONE AND A HALF STOREY (1 ½) SEMI-DETACHED FACTORY ERECTED THEREON LOCATED AT TAMAN PERINDUSTRIAN BUKIT SERDANG, SEKSYEN 7, 43300 SERI KEMBANGAN, SELANGOR DARUL EHSAN, FOR A TOTAL CASH CONSIDERATION OF RM5,247,000.00 ("PROPOSED ACQUISITION")
The Board of Directors of LKL International wishes to announce that its wholly-owned subsidiary, LKL Advance Metaltech Sdn. Bhd. had on 20 October 2016 entered into a Sale and Purchase Agreement with Jengkal Semaju Sdn. Bhd. for the acquisition of all that piece of freehold land together with a one and a half (1 ½) storey semi-detached factory erected thereon located at Taman Perindustrian Bukit Serdang, Seksyen 7, 43300 Seri Kembangan, Selangor Darul Ehsan, for a total cash consideration of RM5,247,000.00 only, inclusive of goods and services tax. Further details of the Proposed Acquisition are as attached. This announcement is dated 20 October 2016.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5236609

Attachments LKL - Acq of property.pdf

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	LKL INTERNATIONAL BERHAD ("LKL INTERNATIONAL" OR "THE COMPANY")PROPOSED ACQUISITION OF ALL THAT PIECE OF FREEHOLD LAND TOGETHER WITH A ONE AND A HALF STOREY (1 ½) SEMI-DETACHED FACTORY ERECTED THEREON LOCATED AT TAMAN PERINDUSTRIAN BUKIT SERDANG, SEKSYEN 7, 43300 SERI KEMBANGAN, SELANGOR DARUL EHSAN, FOR A TOTAL CASH CONSIDERATION OF RM5,247,000.00 ("PROPOSED ACQUISITION")
(Unless otherwise defined in the announcement, all terms used herein shall have the same meaning as those defined in the announcement dated 20 October 2016) Reference is made to the Company’s announcement made on 20 October 2016 in relation to the Proposed Acquisition. The Company wishes to further announce on the following: Net book value of the Property (based on Vendor’s latest audited financial statements as at 30 June 2016) RM2,096,984.28 Existing use of the Property Assembly and storage of electrical switchboard Encumbrances The Property is presently charged to Public Bank Berhad as security for a loan granted to the Vendor This announcement is dated 21 October 2016.

icy97

LKL国际次季赚143万

2016年12月10日
（吉隆坡9日讯）LKL国际（LKL，0182，创业板）截至10月31日次季净赚143万令吉或每股0.33仙，而营业额则达853万7000令吉。

该公司今日向马交所报备，营业额是来自病床及周边医疗用品和配件销量，分别达238万和427万令吉。

同时，LKL国际的国内市场持续带来显著的贡献，达612万令吉，占公司总营业额的71.69%比重。

合计上半年，该集团取得305万7000令吉的净利，以及2046万1000令吉的营业额。

由于该公司在今年5月才上市，而这是第一份中期财报，因此无法作出按年比较。【e南洋】

SUMMARY OF KEY FINANCIAL INFORMATION 31 Oct 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Oct 2016	31 Oct 2015	31 Oct 2016	31 Oct 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	8,537		20,461
2	Profit/(loss) before tax	1,928		4,142
3	Profit/(loss) for the period	1,430		3,057
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,430		3,057
5	Basic earnings/(loss) per share (Subunit)	0.33		0.72
6	Proposed/Declared dividend per share (Subunit)	0.00		0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1400		0.1100

icy97

LKL国际396万
买TRUMPF全自动打孔机

2017年1月24日
（吉隆坡23日讯）LKL国际（LKL，0182，创业板）宣布，以83万欧元（约396万令吉）向全球最大机器供应商TRUMPF集团，购买全自动电脑数值控制工具（CNC）打孔机。

该公司今日向马交所报备，独资子公司LKL先进医疗器材人有限公司，与TRUMPF集团子公司大马TRUMPF私人有限公司，签署采购合约。如无意外，该机械将预计会在付款后的7个月内运抵，并安装在总公司后方，新收购的工厂里。

该机械的购入，符合LKL国际提高营运效率和加工精度的长期计划，以满足未来额外的销售订单。

LKL国际董事经理林观年说：“我国今年获《国际生活》（International Living）生活杂志推选为最佳保健第一名。”

“槟城政府放眼投资10亿令吉，改善现有的医疗保健领域。因此，我们预计，会有更多机会扩展业务，满足客户未来更高需求。”【e南洋】

Type	Announcement
Subject	OTHERS
Description	LKL INTERNATIONAL BERHAD ("LKL INTERNATIONAL" OR "COMPANY")- LKL INTERNATIONAL BERHAD PURCHASE SECOND CNC MACHINE TO INCREASE PRODUCTIVITY
We are pleased to attach a press release dated 23 January 2017 entitled "LKL International Berhad purchase second CNC Machine to increase productivity".

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5322629

Attachments Press Release - LKL INTERNATIONAL BERHAD PURCHASE SECOND CNC MACHINE.pdf

Tony-Pua

LKL國際設聯營公司 分銷Nihon Kohden醫療設備
2017年3月01日
http://www.chinapress.com.my/20170301/lkl國際設聯營公司-分銷nihon-kohden醫療設備/

（吉隆坡1日訊）LKL國際（LKL，0182，創業板消費）與TMI方案私人有限公司成立聯營公司，在國內分銷Nihon Kohden品牌醫療設備。

該公司發布文告指出，聯營公司TMI Medik集團私人有限公司將執行上述業務。

LKL國際董事經理林觀年代表公司與TMI董事克里山達簽署協議。在該協議下，LKL國際與TMI方案分別持有70%和30%股權，並獲得Nihon Kohden新加坡私人有限公司發出的獨家分銷權，至少為期3年。

林觀年說：“我們很開心加入這個聯營項目，並且攝取各自的專才、經驗和資源，確保交付最高素質產品和服務。”

LKL國際相信新業務將貢獻短期盈利表現。

目前，TMI與醫療設備製造商合作，為斯里蘭卡市場供應醫療產品。Nihon Kohden機構在東京交易所上市，主要製造、發展和分銷醫療設備。

Type	Announcement
Subject	OTHERS
Description	LKL INTERNATIONAL BERHAD ("LKL INTERNATIONAL" OR "COMPANY")JOINT VENTURE AGREEMENT BETWEEN MEDIK GEN SDN. BHD. AND LKL ADVANCE METALTECH SDN. BHD., THE WHOLLY-OWNED SUBSIDIARIES OF LKL INTERNATIONAL, WITH T.M.I SOLUTIONS (PVT) LTD
The Board of Directors of LKL International wishes to announce that its wholly-owned subsidiaries, Medik Gen Sdn. Bhd. and LKL Advance Metaltech Sdn. Bhd., had on 1 March 2017 entered into a Joint Venture Agreement with T.M.I Solutions (Pvt) Ltd to form and incorporate a joint venture company, TMI Medik Group Sdn. Bhd. solely to carry out the business of distributing selected “Nihon Kohden” branded medical devices within Malaysia. Please refer to the attachment for additional information. This announcement is dated 1 March 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5353809

Attachments LKL - MEDIK GEN TMI LKLAM_JV @ 010317.pdf

icy97

LKL国际第三季净利跌48%
By Syahirah Syed Jaafar / theedgemarkets.com   | March 20, 2017 : 8:38 PM MYT

（吉隆坡20日讯）LKL国际（LKL International Bhd）第三季净利跌48%，主要因为医疗用品销售下降。

这家医疗保健床和辅助设备制造商今日向大马交易所公布，截至1月杪的2017财政年第三季，净利为121万令吉，低于上财年同期的235万令吉。

第三季营业额从1178万令吉，跌38%至734万令吉。

LKL指出，市况不佳导致其产品销售下降。

2017财年首9个月，净利为427万令吉，较同期的413万令吉，增长3.4%；营业额由2784万令吉，略跌至2780万令吉。

展望未来，该集团预计，最近公布的企业计划将对业绩作出贡献。

这些计划包括购买一台全自动电脑数控（CNC）冲孔机，以提高营运效率和减低对人力劳动的依赖。这预计在2018财年第二季投运。

LKL还与斯里兰卡的TMI Solutions私人有限公司联营，在大马分销特定的“Nihon Kohden”品牌医疗设备。该联营公司预期在2018财年首季开业。

（编译：陈慧珊）

SUMMARY OF KEY FINANCIAL INFORMATION 31 Jan 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Jan 2017	31 Jan 2016	31 Jan 2017	31 Jan 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	7,341	11,781	27,802	27,838
2	Profit/(loss) before tax	1,634	2,994	5,776	5,633
3	Profit/(loss) for the period	1,212	2,346	4,269	4,129
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,212	2,346	4,269	4,129
5	Basic earnings/(loss) per share (Subunit)	0.28	117.30	1.01	206.45
6	Proposed/Declared dividend per share (Subunit)	0.35	0.00	0.35	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1400		0.1100

icy97

EX-date	03 Apr 2017
Entitlement date	05 Apr 2017
Entitlement time	05:00 PM
Entitlement subject	Interim Dividend
Entitlement description	First Interim Single-Tier Dividend of 0.35 sen per share
Period of interest payment	to
Financial Year End	30 Apr 2017
Share transfer book & register of members will be	to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHDUnit 32-01, Level 32, Tower AVertical Business SuiteAvenue 3, Bangsar SouthNo. 8, Jalan Kerinchi59200 Kuala Lumpur
Payment date	28 Apr 2017
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	05 Apr 2017
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.0035
Par Value	Malaysian Ringgit (MYR) 0.000

icy97

LKL国际末季转盈21.5万

2017年6月28日
（吉隆坡28日讯）LKL国际（LKL，0182，创业板）截至4月30日末季，净赚21万5000令吉；去年蒙亏61万2000令吉。同期营业额跌34.6%，报609万1000令吉。

累计全年，净利涨37%至448万4000令吉；营业额萎缩8.8%，报3389万3000令吉。

LKL国际向交易所报备，营业额滑落是因为医疗及保健床业务的营业额减少。

无论如何，本地市场仍贡献显著份额，占营业额67.03%。

虽然营商和营运环境充满挑战，但LKL国际依旧谨慎乐观看待表现，并将持续寻求新增长机会。

另外，与T.M.I解决方案的联营，已在2018财年首季开始经销特定“日本光电”（Nihon Kohden）产品，估计可带来贡献。

LKL国际董事经理林观年，通过文告表示，自联营开始营运后，公司预计会通过新的医疗设备业务，推动增长。

“制造业务方面，我们新的全自动电脑数值控制工具（CNC）打孔机，预计8月送抵，这可提升产量和效率，最终，会增强获利能力和取得长期永续能力。”【e南洋】

SUMMARY OF KEY FINANCIAL INFORMATION 30 Apr 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Apr 2017	30 Apr 2016	30 Apr 2017	30 Apr 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,091	9,311	33,893	37,149
2	Profit/(loss) before tax	283	-498	6,059	4,890
3	Profit/(loss) for the period	215	-612	4,484	3,272
4	Profit/(loss) attributable to ordinary equity holders of the parent	215	-612	4,484	3,272
5	Basic earnings/(loss) per share (Subunit)	0.05	-0.19	1.05	1.04
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.35	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1400		0.1100

icy97

Type	Announcement
Subject	OTHERS
Description	LKL INTERNATIONAL BERHAD ("LKL INTERNATIONAL" OR "COMPANY")- LKL INTERNATIONAL NET PROFIT RISES 37.0% TO RM4.5 MILLION IN FINANCIAL YEAR ENDED 30 APRIL 2017
We are pleased to attach a press release dated 28 June 2017 entitled "LKL International net profit rises 37.0% to RM4.5 million in financial year ended 30 April 2017". Please refer attachment below. This announcement is dated 28 June 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5472061

Attachments LKL_4Q17_PR_Final_170628.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Jul 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Jul 2017	31 Jul 2016	31 Jul 2017	31 Jul 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	4,825	11,924	4,825	11,924
2	Profit/(loss) before tax	-912	2,214	-912	2,214
3	Profit/(loss) for the period	-912	1,627	-912	1,627
4	Profit/(loss) attributable to ordinary equity holders of the parent	-859	1,627	-859	1,627
5	Basic earnings/(loss) per share (Subunit)	-0.20	0.39	-0.20	0.39
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1400		0.1400

icy97

建新厂增产 探索新产品
LKL冀营收单位数增长

2017年9月26日
（吉隆坡26日讯）由于设立新厂房、逐步加强营运效率和产能，以及探索新产品，医疗保健床与设备制造商LKL国际（LKL，0182，创业板），放眼2018财年营业额取得单位数增长。

LKL国际董事经理林观年，今日出席股东常年大会后，向《南洋商报》发表言论。

“在新厂房建设完成后，就会开始投入生产制造；相信将提高公司的营运效率和产能，减少对劳力的依赖，进而推动公司的财务表现。”

新厂明年完工

上述新厂房坐落于史里肯邦安，目前正处于装修阶段，料2018年次季竣工。

“这是公司的第3座厂房，它的隔壁则是第1座和第2座厂房，在厂房完成后，估计可提高产能30%。”

他点出，2017和2018财年的资本开销共约1200万令吉，其中510万令吉用于建设新厂房，有540万令吉为购买生产机器；剩余的150万令吉则作为装修厂房费。

此外，林观年透露，该公司正致力探索新产品，以拓展新的客户群。

“现在还未能公布新产品，未来将会宣布详情。”

LKL国际的主要业务，是从事设计和制造医疗用途病床、周边医疗用品和配件，并销售予国内外私人和政府医院及医疗中心。

他说，设计和制造医疗用途病床业务，和周边医疗用品和配件业务，分别占总营业额的40%和60%。

不过，前者仍是公司的主要业务。

他进一步补充，国外销售则贡献总营业额28%。

人口老化医疗需求殷切

另外，与T.M.I解决方案私人有限公司的联营，并持有70%的股权，已在2018财年首季开始经销特定的“日本光电”（Nihon Kohden）产品。

林观年说道：“这项新成立的医疗设备业务，仍处于初步阶段，相信未来几年可为公司带来贡献。”

展望未来，他认为随着人口老龄化的加速，对医疗服务潜在需求日益增加，相信未来大马将会设立更多政府与私人医院和诊所。

“雪隆区政府医院求诊人数激增，我国医疗旅游表现也相当优越，不过，医院却处于供不应求的状态。”

冀预算案增拨款

被询及即将公布的财政预算案愿望清单，林观年提出，希望政府增加医疗保健预算，照顾人民福祉。

该公司今日报23仙，平盘，成交量为22万3000股。

首季转亏86万

LKL国际截至7月31日首季，蒙受净亏85万9000令吉，或每股0.2仙。

LKL国际今日向马交所报备，上财年同期净赚162万7000令吉或每股0.39仙。

营业额按年下滑59.54%，报482万5000令吉，归咎于市场情绪疲软，使制造和贸易业务贡献下跌。

该公司补充，营业额按年对比较大，因为去年同季拥有本地客户的大型订单入账。

LKL国际点出，产品组合的低赚幅使盈利下跌。

该集团的业绩，与我国和全球医疗保健领域的资本开销息息相关，且2018财年医疗保健领域投资活动较少，加上原材料成本走高，预计将影响短期内的需求。

展望未来，该集团计划通过医疗器材产品分销业务，维持多元化的营业额来源，迎合多变的市场需求，提供更高价值的产品来提升产品组合。【e南洋】

icy97

ype	Announcement
Subject	OTHERS
Description	LKL INTERNATIONAL BERHAD ("LKL" OR "THE GROUP")- REVISION IN EXPANSION PLANS
The Board of Directors of LKL wishes to announce that it had deliberated and approved the revision to the expansion plans that were earlier proposed in 2016 with regard to the following:- (a) Expansion of manufacturing plant (“Expansion”) subsequent to amalgamation of No. 1 Jalan BS7/18, Kawasan Perindustrian Bukit Serdang, Seksyen 7, 43300 Seri Kembangan, Selangor Darul Ehsan (“Factory Lot No. 1”) and No. 3, Jalan BS7/18, Kawasan Perindustrian Bukit Serdang, Seksyen 7, 43300 Seri Kembangan, Selangor Darul Ehsan (“Factory Lot No. 3”); and (b) Removal of single storey metal sheet cladded steel structure extension which were not in accordance to the approved building plans (“Extension”) across Factory Lot No. 1 for the storage of inventory work-in-progress and finished goods and Factory Lot No. 3 for storage of moulds (“Removal of Extension”). In order to boost the efficiency of the Group’s production processes and increase the future capacity of its manufacturing plant, the Board now plans to construct a four-storey steel structure extension across Factory Lot No. 1 and Factory Lot No. 3 (“Four-storey Extension”), in place of the single-storey structure as originally intended. With the Four-storey Extension, it would increase the total built-up area by 37,400 sq ft. This would enable the Group to install a conveyor line to partially automate our epoxy powder coating process and increase storage area for our finished products as originally planned, as well as additional space to carry out the activities currently carried out at the Extension. In line with the revision in plans to construct the Four-storey Extension and availability of additional space, the Board had deliberated and deemed it fit to reconsider and put on hold the original plans for the Removal of Extension within 20 months from our date of Listing, so as to keep up its smooth production efficiency, without disrupting current operations and fulfilment of customer orders.  Subsequent to the completion of the Four-storey Extension, the Board intends to relocate the activities currently carried out within the Extension into the Four-storey Extension within two (2) months and undertakes to complete the Removal of Extension within two (2) months thereafter. Nonetheless, the Board is cognisant of the legal implications in the event that the relevant authorities take action in respect of the current Extension. The estimated timeline to undertake the Four-storey Extension is approximately 36 months, consisting of: Submission and approval of the amalgamated land title from the Land Office: Estimated 6 months Submission and approval of plans for the Four-storey Extension from Majlis Perbandaran Subang Jaya: Estimated 6 months Construction of Four-storey Extension: Approximately 18 months Final approval and obtainment of certification of completion and compliance for the Four-storey Extension: Approximately 6 months This announcement is dated 15 November 2017.

icy97

LKL国际次季转盈30万

2017年12月14日
（吉隆坡13日讯）LKL国际（LKL，0182，创业板）截至10月31日财年次季，营业额按季激增48.5%，达720万令吉，是2017年首季以来首次增长。

同期净赚30万令吉，上季度乃净亏90万令吉。

LKL国际表示，次季营业额与净利按季齐齐改善，归功于旗下所有业务更强劲，而这也是保健开销逐步改善的指标。

董事经理林观年通过文告表示，虽然谨慎看待充满挑战的营运环境，但将持续采取策略，在保健领域开始复苏之际，为增长定位。

按年比较，当季营业额则是走跌16%，归咎于旗下制造及贸易活动的贡献减少，主要因为环境充满挑战，且市况疲弱。

净利按年则大幅萎缩73.5%，与营业额的跌势相符。LKL国际解释，这是因为赚幅疲软。

累计首两季，该公司仍蒙受48万1000令吉净亏损。【e南洋】

SUMMARY OF KEY FINANCIAL INFORMATION 31 Oct 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Oct 2017	31 Oct 2016	31 Oct 2017	31 Oct 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	7,166	8,537	11,991	20,461
2	Profit/(loss) before tax	287	1,928	-625	4,142
3	Profit/(loss) for the period	287	1,430	-625	3,057
4	Profit/(loss) attributable to ordinary equity holders of the parent	378	1,430	-481	3,057
5	Basic earnings/(loss) per share (Subunit)	0.09	0.33	-0.11	0.72
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1400		0.1400

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Jan 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Jan 2018	31 Jan 2017	31 Jan 2018	31 Jan 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	10,246	7,341	22,237	27,802
2	Profit/(loss) before tax	1,064	1,634	439	5,776
3	Profit/(loss) for the period	838	1,212	213	4,269
4	Profit/(loss) attributable to ordinary equity holders of the parent	893	1,212	412	4,269
5	Basic earnings/(loss) per share (Subunit)	0.21	0.28	0.10	1.01
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1400		0.1400